NASDAQ IPO

Quantinuum debuted on Nasdaq with a $15.7 billion valuation, raising $1.68 billion. The company offers a full-stack quantum computing platform, serving diverse sectors. Despite a recent revenue dip, the company received significant government investment and benefits from broad industry interest in quantum technology’s potential to revolutionize fields like drug discovery and materials science.

Delixy Holdings priced its Nasdaq IPO at $4.00/share, raising $5.4 million from 1.35M primary and 650K secondary shares. Trading begins July 9, 2025 (ticker DLXY) at an $8M valuation, with Bancroft Capital underwriting. Proceeds will target expansion in Southeast Asia and Middle East oil markets. Positives include capital for growth and Nasdaq credibility, while concerns involve the modest scale and significant secondary offering (32.5% of IPO shares).